These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 310279)

  • 61. Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin.
    Bergeron MG; Claveau S; Simard P
    Antimicrob Agents Chemother; 1981 Jan; 19(1):101-5. PubMed ID: 6454379
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The inhibition of staphylococcal beta-lactamase by clavulanic acid.
    Reading C; Hepburn P
    Biochem J; 1979 Apr; 179(1):67-76. PubMed ID: 38773
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. II. Antibacterial properties.
    Angehrn P; Arisawa M
    J Antibiot (Tokyo); 1982 Nov; 35(11):1584-9. PubMed ID: 6298168
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro and in vivo synergism between amoxicillin and clavulanic acid against ampicillin-resistant Haemophilus influenzae type b.
    Yogev R; Melick C; Kabat WJ
    Antimicrob Agents Chemother; 1981 Jun; 19(6):993-6. PubMed ID: 6973952
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.
    Tajada P; Gomez-Graces JL; Alós JI; Balas D; Cogollos R
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1924-5. PubMed ID: 8843305
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Rapid determination of the synergy of clavulanic acid and beta lactams by measuring the intracellular ATP by bioluminescence].
    Cornel E; Philippon A; Paul G; Guenounou M
    Ann Microbiol (Paris); 1982; 133(3):365-77. PubMed ID: 6819796
    [TBL] [Abstract][Full Text] [Related]  

  • 68. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
    Van den Ende J; Gricius ME; De Klerk HC; Neiteler BF; Forder AA; Venter L; Hallett AF; Koornhof HJ; Robinson R; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):5A-8A. PubMed ID: 6979805
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pyridinium 2-azo-p-dimethylaniline chromophore, a chromogenic reagent for beta-lactamase testing compared to nitrocefin.
    Barlam T; Neu HC
    Eur J Clin Microbiol; 1984 Jun; 3(3):185-9. PubMed ID: 6332017
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():25-37. PubMed ID: 3875603
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Activity of the beta-lactamase inhibitor BRL 42715 against cephalosporinases produced by Enterobacteriaceae.
    Zhou XY; Kitzis MD; Acar JF; Gutmann L
    J Antimicrob Chemother; 1993 Apr; 31(4):473-80. PubMed ID: 8514645
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The history and background of Augmentin.
    Rolinson GN
    S Afr Med J; 1982 Jul; 62(5 Spec No):3A-4A. PubMed ID: 6979804
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of clavulanic acid on minimal inhibitory concentrations of 16 antimicrobial agents tested against Legionella pneumophila.
    Pohlod DJ; Saravolatz LD; Quinn EL; Somerville MM
    Antimicrob Agents Chemother; 1980 Aug; 18(2):353-4. PubMed ID: 6969575
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1985 Sep; 16(3):305-13. PubMed ID: 2997100
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Serotype distribution and drug resistance of
    Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
    Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
    [No Abstract]   [Full Text] [Related]  

  • 78. Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae.
    Livermore DM; Mushtaq S; Nguyen T; Warner M
    Int J Antimicrob Agents; 2011 May; 37(5):405-9. PubMed ID: 21276715
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.
    Fu KP; Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097
    [TBL] [Abstract][Full Text] [Related]  

  • 80. beta-Lactamase inhibitory activity of iodopenicillanate and bromopenicillanate.
    Neu HC
    Antimicrob Agents Chemother; 1983 Jan; 23(1):63-6. PubMed ID: 6299186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.